No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs3807375 |
chr7:150667210-150667211 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundancedisease
|
2 |
rs544805947 |
chr7:150667217-150667218 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs552118151 |
chr7:150667277-150667278 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs369043768 |
chr7:150667304-150667305 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs41308981 |
chr7:150667347-150667348 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs41308984 |
chr7:150667349-150667350 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs182514979 |
chr7:150667353-150667354 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs372257847 |
chr7:150667354-150667355 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs150286129 |
chr7:150667361-150667362 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs137909495 |
chr7:150667362-150667363 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs143492904 |
chr7:150667363-150667364 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs145888505 |
chr7:150667395-150667396 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs549271497 |
chr7:150667398-150667399 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs138755795 |
chr7:150667450-150667451 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs150987673 |
chr7:150667491-150667492 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs569411981 |
chr7:150667498-150667499 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs115564829 |
chr7:150667507-150667508 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs41307343 |
chr7:150667533-150667534 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs7792983 |
chr7:150667639-150667640 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs528167743 |
chr7:150667643-150667644 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs118121666 |
chr7:150667664-150667665 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs575974241 |
chr7:150667683-150667684 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs544929398 |
chr7:150667711-150667712 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs115937974 |
chr7:150667712-150667713 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs574877658 |
chr7:150667748-150667749 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs142127098 |
chr7:150667755-150667756 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs560612596 |
chr7:150667774-150667775 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs146163983 |
chr7:150667778-150667779 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs552317715 |
chr7:150667834-150667835 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs562353611 |
chr7:150667858-150667859 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs75562728 |
chr7:150667869-150667870 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs548074824 |
chr7:150667878-150667879 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs568052884 |
chr7:150667879-150667880 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs147862727 |
chr7:150667880-150667881 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs547102681 |
chr7:150667930-150667931 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs572719880 |
chr7:150668027-150668028 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs189467962 |
chr7:150668069-150668070 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs10236214 |
chr7:150668070-150668071 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs578125157 |
chr7:150668126-150668127 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs539175232 |
chr7:150668164-150668165 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs559153806 |
chr7:150668167-150668168 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs11763131 |
chr7:150668182-150668183 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs576503557 |
chr7:150668221-150668222 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs543535440 |
chr7:150668227-150668228 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs545040329 |
chr7:150668228-150668229 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs3807374 |
chr7:150668346-150668347 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs141429994 |
chr7:150668355-150668356 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs560303391 |
chr7:150668380-150668381 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs577229085 |
chr7:150668381-150668382 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs150434008 |
chr7:150668405-150668406 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|